Chemistry support for

building partnerships

CTX LIFESCIENCES PVT LTD

An integrated Partner throughout API Cycle

US FDA/EU GMP Certified/PMDA Accreditation

and compliant

Who we are
Colourtex, a 40-year old largest dyes and intermediates
company in India with over 2000 employees and annual
revenues of USD 250 millions, diversified into
Pharmaceuticals in 2004
Privately held Company headquartered in Surat, 260 kms
north of Mumbai. Surat - a major hub for Chemicals and
Diamonds
Commercial production started in the state-of-the-art greenfield facility during second quarter of 2006
Presence in anti-infectives, CVS, CNS, anti-diabetes and
other segments

Our Vision

To be the preferred strategic partner for the

pharmaceutical industry and share responsibilities &
goals for the enhancement of human health.

Our Mission

To develop and manufacture Active

Pharmaceutical Ingredients and Intermediates
for global supply complying to quality and
regulatory requirements of our customers.

Our Mfg Strengths and Plans

US FDA inspected and accepted facility, EUGMP
Certified and Japan Accredited with over 200,000 sq.ft
area spread on 38 acres of land. One facility for all
markets. Large intermediate plant.
Cost effective operating structure with vertical integration
in some products
Skilled workforce and competent technical & management
team with global and global pharma experience
Total number of reactors : 83 Nos.
Total reactors volume : 236 meter cube
Total number of people : 296

Our Mfg Strengths and Plans

Access to own large infrastructure, viz. water reservoirs,
power generation, effluent treatment plant, landfill site and
incinerators. Also, large intermediate plant
Can handle complex chemical reactions viz., cynation,
nitration, chlorosulfonation, hydrogenation and ethoxylation
Investment over USD 27 millions
US DMF filed for 18 products and 5 approved. CEP filed for
9 products and 8 approved.
Validations completed for Quetiapine and Candesartan

Product Range

Acetazolamide
Amiodarone
Alendronate Sodium
Carbamazepine
Carvedilol
Chlorothiazide
Colesevelam
Candesartan
Hydrochlorothiazide
Irbesartan
Lamotrigine
Metoprolol Tartrate/Succinate
Olmesartan
Oxcarbazepine
Oxymetazoline/Xylometazoline
Pregabalin
Quetiapine
Sevelamer HCl/Carbonate
Terazosin

Terbinafine

Why partner with CTX Lifesciences

Chemistry competence over forty years

Excellent infrastructure viz. water, power, disposal of gaseous, liquid and solid organic
wastes and financial strength

cGMP compliant state of the art facility with focus on API and Intermediates. Facility
audited by Astra Zeneca, Glaxo, Novartis, EMerck, Aventis,, Teva, Mylan, Sandoz,
Actavis, Siegfried, Pliva and visit by Pfizer and found to comply their requirements.

US FDA inspected and accepted facility; PMDA accreditation and EUGMP Certified.

Plan to file at least 5 DMFs in 2013

Experienced technical and commercial team with global and global pharma experience.

Vertical integration on Hydrochlorothiazide, Xylometazoline, Oxymetazoline, Irbesartan

Sevelamer, Colesevalam, and Lamotrigine and working on Metoprolol Tartrate,
Succinate and Oxcarbazepine

Environment, Safety and Health Practices

Manufacturing and R&D

Thank You